Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02157038 · ClinicalTrials.gov registry record · NA
Neuromuscular Mechanisms Underlying Poor Recovery From Whiplash Injuries
A NA study of Whiplash Associated Disorders and WAD, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 97
- Enrollment target
- 1
- Study location
NCT02157038: Completed NA study of Whiplash Associated Disorders and WAD, sponsored by Northwestern University.
NCT02157038 is a NA study of Whiplash Associated Disorders and WAD that has completed, run by Northwestern University. The registered enrollment target is 97 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02157038, a NA study of Whiplash Associated Disorders and WAD, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is investigating whether changes in the shape and size of bodily muscles and spinal cord anatomy can influence recovery rates following a motor vehicle collision (MVC). The objective is to demonstrate that the presence of muscle and spinal cord degeneration and associated muscle weakness is the consequence of a mild MVC-related injury involving the cervical spinal cord.
Conditions Studied
Interventions
- DEVICE MRI
- DEVICE Pedometer
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2014-07 |
| Est. Completion | 2020-05 |
| Phase | NA |
What the finished NCT02157038 record still lists
NCT02157038 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 97 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Whiplash Associated Disorders appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.
NCT02157038 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02157038 about?
NCT02157038 is a clinical study titled "Neuromuscular Mechanisms Underlying Poor Recovery From Whiplash Injuries". This study is investigating whether changes in the shape and size of bodily muscles and spinal cord anatomy can influence recovery rates following a motor vehicle collision (MVC). The objective is to demonstrate that the presence of muscle and spinal cord degeneration and associated muscle weakness ...
What is the current status of trial NCT02157038?
This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2014-07. Estimated completion is 2020-05.
What conditions does trial NCT02157038 study?
This clinical trial studies the following conditions: Whiplash Associated Disorders, WAD, Whiplash.
What interventions are being tested in trial NCT02157038?
The interventions under investigation include: MRI (DEVICE), Pedometer (DEVICE).
Who is sponsoring clinical trial NCT02157038?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02157038 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02157038's enrollment target sits among peer trials
97 923rd of 2000 higher than 1,076 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03948490 · 97 participants · NA
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
- NCT04140487 · 97 participants · Phase 1
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- NCT04196413 · 97 participants · Phase 1
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
- NCT05223816 · 97 participants · Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia